Table A2.
Domain | No. | Search Terms: TITLE-ABS-KEY |
---|---|---|
P 1 | #1 | “breast cancer” |
#2 | “breast neoplasms” | |
P 1 | #3 | #1 OR #2 |
P 2 | #4 | “human epidermal growth factor receptor 2” |
#5 | “HER2” | |
#6 | “ERBB2” | |
P 2 | #7 | #4 OR #5 OR #6 |
P | #8 | P1 AND P2 #3 AND #7 |
I 1 | #9 | “neoadjuvant” |
#10 | “pre operative” | |
#11 | #9 OR #10 | |
I 2 | #12 | “anti HER2” OR “anti human epidermal growth factor receptor 2” |
#13 | “targeted therapy” | |
#14 | “trastuzumab” OR “Herceptin” | |
#15 | “pertuzumab” OR “perjeta” | |
#16 | “lapatinib” OR “Tykerb” OR “Tyverb” | |
#17 | #12 OR #13 OR #14 OR #15 OR #16 | |
I | #18 | I 1 OR I 2 #11 OR #17 |
O 1 | #19 | “complete response” |
O 2 | #20 | “survival” |
O 3 | #21 | “adverse event” |
O | #22 | O1 OR O2 OR O3 #19 OR #20 OR #21 |
S | #23 | “randomized controlled trial” |
Combinations | ||
P, I, O | #8 AND #18 AND #22 | |
P, I, O, S | #8 AND #18 AND #22 AND #23 |